• Practice Areas
  • Sectors
  • Lawyers
  • Notaries



GSK Update: AIFM Marketing in Germany - The clock is ticking for U.S. and other non-EU fund managers

Our GSK Update informs about the impact of recent German investment fund legislation (UCITS V Implementation Act) for AIF managers, who are not domiciled in the EU (“non-EU-AIFM”) and who seek to market AIF shares in Germany in accordance with applicable German investment fund law under the EU-AIFM Directive (2011/61/EU).

This GSK Update summarizes that there is a material risk that the available timeframe for filing marketing notifications for non-EU-AIF to BaFin will very likely expire this year with potential impacts for many non-EU jurisdictions, particularly the United States.

Contact at GSK Stockmann + Kollegen:
Dr. Markus Escher
Daniela Eschenlohr
Dr. Marcus Peter